Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC VPC-80051 racemate | 877969-69-2 | 99.0% | 301.29 g·mol⁻¹ | C16H13F2N3O | 50MG
SDP

Catalog No. 5000235019
Encompass_Preferred

VPC-80051 racemate is the racemic form of a small-molecule inhibitor targeting the hnRNP A1 splicing factor. It binds the hnRNP A1 RNA-binding domain and has been shown to reduce AR-V7 mRNA levels in 22Rv1 castration-resistant prostate cancer cells, making it suitable as a research reagent for in vitro studies of splicing regulation and AR-V7 biology.

  • Racemic small-molecule inhibitor of hnRNP A1 splicing activity.
  • Demonstrated reduction of AR-V7 mRNA in 22Rv1 cells.
  • Intended for in vitro biochemical and cell-based assays.
  • Molecular formula C16H13F2N3O; molecular weight 301.29 g·mol⁻¹.
  • High purity (98.99%) appropriate for research use.

Catalog No. 50-002-35019 Supplier Medchemexpress LLC Supplier No. HY12607650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

VPC-80051 racemate is the racemic form of a small-molecule inhibitor targeting the hnRNP A1 splicing factor. It binds the hnRNP A1 RNA-binding domain and has been shown to reduce AR-V7 mRNA levels in 22Rv1 castration-resistant prostate cancer cells, making it suitable as a research reagent for in vitro studies of splicing regulation and AR-V7 biology.

  • Racemic small-molecule inhibitor of hnRNP A1 splicing activity.
  • Demonstrated reduction of AR-V7 mRNA in 22Rv1 cells.
  • Intended for in vitro biochemical and cell-based assays.
  • Molecular formula C16H13F2N3O; molecular weight 301.29 g·mol⁻¹.
  • High purity (98.99%) appropriate for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.